natgillin/translations-raw huggingface dataset:
Computer program product having stored thereon instructions for performing the method according to one of claims 1-4. 
Proizvod računalnog programa koji sadrži upute za provođenje postupka prema jednom od zahtjeva 1-4.
arranging in the hold (7) the self-contained tank module (11) to provide a tanker, wherein 
postavljanje u držač (7) samostalnog modula spremnika (11) kako bi se dobio tanker, pri čemu
the size and shape of the tank module (11) are such that once arranged in the hold (7), the part of the tank module that is arranged in the hold (7) fits the size and shape of the hold (7); and 
veličina i oblik modularnog spremnika (11) su takvi da jednom kada su postavljeni u držač (7), dio modula spremnika koji je postavljen u držač (7) odgovara veličini i obliku držača (7); i
the hatch opening (9) of the hold is closed by means of the tank module (11); 
palubni otvor (9) držača se zatvara pomoću modularnog spremnika (11);
arranging above the main deck (25) an outfitting comprising conduits (55) for loading a liquid to be transported into the cargo tanks (61, 63, 65, 67) of the tank module (11) and for unloading the liquid from the cargo tanks after transport; 
te postupak nadalje sadrži korak: postavljanja iznad glavne palube (25) opreme koja obuhvaća vodove (55) za punjenje tekućine koja se prevozi u spremnicima za teret (61, 63, 65, 67) modularnog spremnika (11) i za pražnjenje tekućine iz spremnika za teret nakon transporta;
preferably further comprising after the step of removing the tank module (11a) the step of arranging via the hatch opening (9a) a replacement tank module (11f) in the hold. 
poželjno nadalje nakon koraka uklanjanja modula spremnika (11a) sadrži korak slaganja preko palubnog otvora (9a) zamjenskog modula spremnika (11f) u držač.
Tanker (1), preferably a parcel tanker, comprising 
Tanker (1), poželjno tanker s odjeljcima, koji obuhvaća
a self-contained tank module (11) comprising a number of cargo tanks, wherein 
samostalni modul spremnika (11) koji sadrži veći broj spremnika za teret, pri čemu je
Tanker according to any of claims 6 to 13, wherein the tank module (11) comprises walls enclosing an inner space, wherein preferably the internal space is divided in a plurality of tanks, preferably by means of internal walls; 
Tanker prema bilo kojem od zahtjeva 6 do 13, naznačen time da modul spremnika (11) sadrži stjenke koje okružuju unutrašnji prostor, pri čemu je poželjno unutrašnji prostor podijeljen u mnoštvo spremnika, poželjno pomoću unutrašnjih stjenki;
wherein preferably the walls (17) of the tank module are made of stainless steel. 
pri čemu su poželjno stjenke (17) modularnog spremnika izrađene od nehrđajućeg čelika.
arranged above the main deck (25) is an outfitting comprising conduits (55) for loading a liquid to be transported into cargo tanks (61, 63, 65, 67) of the tank module (11) and for unloading the liquid from the cargo tanks after transport; 
iznad glavne palube (25) je smještena oprema koja obuhvaća vodove (55) za utovar tekućine koja se prevozi u spremnicima za teret (61, 63, 65, 67) modularnog spremnika (11) i radi istovara tekućine iz spremnika za tereta nakon transporta; i pri čemu
The fusion protein according to claim 1 wherein X is the signal peptide of a protein selected from the group consisting of Flgl, NadA and pelB. 
Fuzijski protein u skladu s patentnim zahtjevom 1, naznačen time što je X signalni peptid iz proteina koji se bira iz skupine koju čine Flgl, NadA i pelB.
The fusion protein according to claim 1 selected from the group consisting of, SEQ ID NO. 
Fuzijski protein u skladu s patentnim zahtjevom 1, naznačen time što se bira iz skupine koju čine SEQ ID NO.
The fusion protein, the immunogenic composition, or the vaccine of claims 1-19 for use in the treatment or prevention of acute exacerbations of chronic obstructive pulmonary disease (AECOPD). 
Fuzijski protein, imunogeni pripravak, ili cjepivo u skladu s patentnim zahtjevima 1-19, naznačeni time što su namijenjeni upotrebi u liječenju ili sprječavanju akutnih egzacerbacija kronične opstruktivne plućne bolesti (AE-COPD).
A PGI2 receptor agonist agent comprising the crystal according to claim 1 or claim 2 as an active ingredient. 
Agonističko sredstvo za PGI2 receptor, naznačeno time što sadrži kristal u skladu s patentnim zahtjevom 1 kao aktivni sastojak.
An agent for treating diabetic neuropathy, diabetic gangrene, peripheral circulatory disturbance, chronic arterial occlusion, intermittent claudication, thrombosis, pulmonary hypertension, myocardial infarction, angina, glomerulonephritis, diabetic nephropathy, chronic renal failure, bronchial asthma, interstitial pneumonia (pulmonary fibrosis), scleroderma, chronic obstructive pulmonary disease, tubulointerstitial nephritis, or symptoms associated with lumbar spinal canal stenosis, comprising the crystal according to claim 1 or claim 2 as an active ingredient. The agent according to claim 5, wherein the agent is for treating pulmonary hypertension. 
Spoj, naznačen time što je namijenjen upotrebi u liječenju dijabetične neuropatije, dijabetične gangrene, poremećaja perifernog krvotoka, kroničnog začepljenja arterija, povremenog šepanja, tromboze, plućne hipertenzije, infarkta miokarda, angine, glomerulonefritisa, dijabetične nefropatije, kronične insuficijencije bubrega, bronhijalne astme, intersticijske pneumonije (plućne fibroze), skleroderme, kronične opstruktivne plućne bolesti, upalne bolesti crijeva, tubulointersticijskog nefritisa, ili simptoma povezanih s lumbalnom stenozom kralježničnog kanala, gdje je spoj kristal u skladu s patentnim zahtjevom 1.
A pharmaceutical composition comprising a compound of any one of claims 1-8, and a pharmaceutically acceptable carrier, adjuvant or vehicle. 
Farmaceutski sastav, naznačen time, da obuhvaća spoj prema zahtjevu 1 i farmaceutski prihvatljiv nosač, pomoćno sredstvo ili prijenosno sredstvo.
and a substituted or unsubstituted aryl, wherein the aryl is selected from phenyl or naphthyl; and 
je supstituiran ili nesupstituiran aril, pri čemu je aril odabran od fenila ili naftila; i
The composition of claim 1, formulated as a unit dosage form for once daily administration. 
Kompozicija iz patentnog zahtjeva 3 koja je formulirana kao jedinični dozni oblik za administraciju jednom dnevno.
A polymer for microencapsulation of water-immiscible material, the material to microencapsulate with a solubility in water lower than 750 mg/L at 20°C, said polymer formed by means of an interfacial polymerization reaction and enclosing the water-immiscible material, characterized in that: 
Mikrokapsule koje zatvaraju materijal koji ima topljivost u vodi nižu od 750 mg/l na 20°C, ili klomazon, naznačene time, što se zid mikrokapsula formira reakcijom interfacijalne polimerizacije sljedećih materijala za formiranje zida:
comprising compounds (I) all isomeric and stereoisomeric configurations that may be present depending on the radicals as cited, and been excluded from compounds (I) all the combinations of radicals that are not able to form polyurea-acetylene carbamide derivative (ACD) polymers when such ACDs are reacted as described in the present invention with a mixture of isocyanates. 
spojevi (I) uključuju sve moguće izomerne i streokemijske konfiguracije; zavisno od navedenih radikala, i iz spojeva (I) isključene su sve kombinacije radikala koje ne mogu formirati poliurea-acetilen karbamid derivatne polimere kada su takvi acetilen karbamidni derivati reagirali, kako je opisano u predmetnom pronalasku, s mješavinom izocijanata i odnos materijala koji formiraju zid iznosi alifatični izocijanat:
A polymer according claim 1 where compounds of claim 1 i) (a) are made of a mixture of different aliphatic isocyanates. 
Mikrokapsule prema patentnom zahtjevu 1, naznačene time, što su spojevi iz patentnog zahteva 1 (a) napravljena od mješavine različith alifatičnih izocijanata.
A polymer according claim 1 where compounds of claim 1 i) (b) are made of a mixture of different aromatic isocyanates. 
Mikrokapsule prema patentnom zahtjevu 1, naznačene time, što su spojevi iz patentnog zahtjeva 1 (b) napravljena od mješavine različith aromatičnih izocijanata.
The polymer as defined in claims 1 to 4 characterized in that the substituted acetylene carbamide derivatives' mixture of claim 1 i) (c) as defined in any of the preceding claims, is mainly composed of substituted acetylene carbamide monomeric and/or low oligomerized (from 2 to 10 monomers per molecule) and/or non-polymerized compounds (I), being the content high polymerized monomers -more than 100 monomers per molecule- lower than 10% in weight % with respect the content of monomers in weight percent, preferably less than 0.5% in weight %. 
Mikrokapsule prema patentnom zahtjevu 1, naznačene time, što su spojevi definirani u patentnom zahtjevu 1 (c) mješavina spojeva (I) i ta mješavina je sastavljena od spojeva (I) u monomernoj formi i/ili oligomernoj formi - od 2 do 10 monomera po molekuli - i/ili polimeriziranih spojeva (I), pri čemu je sadržaj polimeriziranih monomera sa više od 100 monomera po molekuli niži od 10%, izraženo u težinskim %, u odnosu na sadržaj monomera izražen u težinskim-%.
The polymer according any suitable preceding claim or combination of preceding claims characterized in that the solution is mainly -as far as the industrial production of compounds (I) allows it- composed of monomeric compounds (I) where all the substituents as characterized in claim 3, R1, R2, R3, R4 are equal among them, R5, R6, R7, R8 are equal among them and R9 and R10 are hydrogen atoms. 
Mikrokapsule prema bilo kojem pogodnom prethodnom patentnom zahtjevu ili kombinaciji prethodnih patentnih zahtjeva, naznačene time, što je/su spoj/spojevi (I) načinjen/načinjeni od monomernog/monomernih spojeva (I) pri čemu su supstituenti R1, R2, R3, R4 jednaki među sobom, R5, R6, R7, R8 su jednaki među sobom, i R9 i R10 su atomi vodika.
The use of microcapsules with a polymeric wall according a suitable combination of claims 1 to 29 or produced according a suitable combination of claims 30 to 40 in an agrochemical formulation characterized in that the microencapsulated material and/or suspended material in the water phase according to claim 35 contains combinations of flurocloridone and/or lambdacyhalothrin and/or clomazone and/or metazachlor and/or alachlor, with other pesticides or agrochemicals, including antidotes, safeners, annelicides and/or semiochemicals. 
Mikrokapsule prema patentnim zahtevima 1 do 27, naznačene time, što je mikroinkapsulirani materijal klomazon. Mikrokapsule prema patentnim zahtjevima 1 do 27, naznačene time, što mikroinkapsulirani materijal i/ili suspendirani materijal u vodenoj fazi prema patentnom zahtjevu 28 sadrži kombinacije flurokloridona i/ili lambda-cihalotrina i/ili klomazona i/ili metazaklora i/ili alaklora, sa drugim pesticidima ili agrokemijskim sredstvima, uključujući antidote, sredstva za povećanje sigurnosti, anelicide i/ili semiokemijska sredstva.
a mixing system (20) for producing a gas mixture (G1+G2); 
sustav miješanja (20) za proizvodnju smjese plinova (G1+G2);
an oiler or nebuliser (30) for nebulising an odorising/aromatising liquid (L) and mixing it with the gas mixture (G1+G2) produced and fed by the mixing system (20); and 
uljilo ili atomizer (30) za atomiziranje odorizirajuće/aromatizirajuće tekućine (L) i njeno miješanje sa smjesom plinova (G1+G2) koju proizvodi i opskrbljuje sustav miješanja (20); i
a tank (40), where the mixture (G1+G2+L) of nebulised liquid and gas is stored and the molecular exchange takes place between this gas mixture, supplied by the mixing system and the nebulised liquid, so as to obtain the odorising/aromatising substance (OD) to be used for odorising the packaging (CON); 
spremnik (40), gdje se čuva smjesa (G1+G2+L) atomizirajuće tekućine i plina i dolazi do molekularne razmjene između smjese plinova, koju dovodi sustav miješanja i atomizirajuće tekućine, tako da se dobivena odorizirajuća/aromatizirajuća supstanca (OD) koristi za odoriziranje pakiranja (CON);
Odorising apparatus (10) according to any one of claims 1 to 4, characterised in that it uses ternary or quaternary mixtures produced by the respective mixing system. 
Uređaj za odorizaciju (10) prema bilo kojem od patentnih zahtjeva 1 do 4, naznačeno time da koristi ternarne ili kvaterne mješavine koje proizvodi odnosni sustav miješanja.
Method for odorising a packaging, such as for example a food-preserving tray, wherein a product (PR), more particularly a food product, is packaged and supplied, comprising the following steps: 
Metoda za odorizaciju pakiranja, primjerice posuda za konzerviranje hrane, u koju se proizvod (PR), osobito prehrambeni proizvod, pakira i isporučuje, koja sadrži slijedeće korake:
measuring at least once a first charge time t1, the first charge time being the time required for the at least one capacitor to reach a specified charge value in the first RC circuit, when the switching means is in the first position, 
mjerenje najmanje jednom prvog vremena nabijanja t1, gdje je prvo vrijeme nabijanja vrijeme potrebno da najmanje jedan kondenzator dosegne specificiranu vrijednost nabijenosti u prvom RC krugu, kada je prekidač u prvom položaju,
activating the switching means to the second position, 
aktiviranje prekidača u drugi položaj,
Method according to any of the previous claims, wherein in step a) the measurement of the time required for the at least one capacitor to reach a specified charge value is taken at least twice and the first charge time t1 is obtained as the mean of the measurements taken. 
Postupak u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačen time što se u koraku a) mjerenje vremena potrebnog da najmanje jedan kondenzator dosegne specificiranu vrijednost nabijenosti provodi najmanje dvaput, a prvo vrijeme nabijanja t1 se dobije kao prosjek provedenih mjerenja.
Method according to any of the previous claims, wherein in step c) the measurement of the time required for the at least one capacitor to reach a specified charge value is taken at least twice and the second charge time t2 is obtained as the mean of the measurements taken. 
Postupak u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačen time što se u koraku c) mjerenje vremena potrebnog da najmanje jedan kondenzator dosegne specificiranu vrijednost nabijenosti provodi najmanje dvaput, a drugo vrijeme nabijanja t2 se dobije kao prosjek provedenih mjerenja.
Microcapsules enclosing material with a solubility in water lower than 750 mg/L at 20°C or clomazone, characterized in that the wall of the microcapsules is formed by means of an interfacial polymerization reaction of the wall forming materials: 
Mikrokapsule koje zatvaraju materijal koji ima topljivost u vodi nižu od 750 mg/l na 20°C, ili klomazon, naznačene time, što se zid mikrokapsula formira reakcijom interfacijalne polimerizacije sljedećih materijala za formiranje zida:
comprising compounds (I) all isomeric and stereochemical configurations that may be present; depending on the radicals as cited, and been excluded from compounds (I) all the combinations of radicals that are not able to form polyurea-acetylene carbamide derivative polymers when such acetylene carbamide derivatives are reacted as described in the present invention with a mixture of isocyanates 
spojevi (I) uključuju sve moguće izomerne i streokemijske konfiguracije; zavisno od navedenih radikala, i iz spojeva (I) isključene su sve kombinacije radikala koje ne mogu formirati poliurea-acetilen karbamid derivatne polimere kada su takvi acetilen karbamidni derivati reagirali, kako je opisano u predmetnom pronalasku, s mješavinom izocijanata i odnos materijala koji formiraju zid iznosi alifatični izocijanat:
and the ratio of wall forming materials is aliphatic isocyanate: aromatic isocyanate from 1: 3 to 1: 1; aromatic isocyanate: acetylene carbamide derivatives from 9: 1 to 4: 1; aliphatic isocyanates: acetylene carbamide derivatives from 2: 1 to 5: 1; and the microcapsules have a mean diameter of 0.3 to 25 µm, and 90% of the microcapsules have a diameter lower than 100 µm, when measured with a conventional laser diffraction particle sizer analyzer, previous customary dilution upon water under agitation. 
aromatični izocijanat od 1: 3 do 1: 1; aromatični izocijanat: acetilen karbamidni derivati od 9: 1 do 4: 1; alifatični izocijanati: acetilen karbamidni derivati od 2: 1 do 5: 1; i mikrokapsule imaju prosječan promjer od 0.3 do 25 μm, i 90% mikrokapsula ima promjer manji od 100 μm, kada se mjeri konvencionalnim laserskim difrakcijskim analizatorom veličine čestica, prethodno uobičajeno otopljenih u vodi, uz protresanje.
Microcapsules according to claim 1 wherein the aromatic isocyanate is prepolymeric aromatic isocyanate. 
Mikrokapsule prema patentnom zahtjevu 1, naznačene time, što je aromatični izocijanat prepolimerni aromatični izocijanat.
Microcapsules according to claim 1 wherein the compounds of claim 1 (a) are made of a mixture of different aliphatic isocyanates. 
Mikrokapsule prema patentnom zahtjevu 1, naznačene time, što su spojevi iz patentnog zahteva 1 (a) napravljena od mješavine različith alifatičnih izocijanata.
Microcapsules according to claim 1 wherein compounds of claim 1 (b) are made of a mixture of different aromatic isocyanates. 
Mikrokapsule prema patentnom zahtjevu 1, naznačene time, što su spojevi iz patentnog zahtjeva 1 (b) napravljena od mješavine različith aromatičnih izocijanata.
Microcapsules according to claim 1, characterized in that compounds of claim 1 (c) are a mixture of compounds (I) in the form of oligomers up to 10 mols per molecule, wherein the sum of the quantity of monomers, dimers, trimers and tetramers at least 75 weight-% of the total weight of compounds (I) . 
Mikrokapsule prema patentnom zahtjevu 1, naznačene time, što su spojevi iz zahtjeva 1 (c) mješavina spojeva (I) u formi oligomera sa do 10 molova po molekuli, pri čemu ukupna količina monomera, dimera, trimera i tetramera iznosi najmanje 75 težinskih-% od ukupne težine spojeva (I).
Microcapsules according to claim 1 characterized in that the compound(s) as defined in claim 1 (c) is one and only one compound of formula (I) . 
Mikrokapsule prema patentnom zahtjevu 1, naznačene time, što je spoj/spojevi kako je definirano u patentnom zahtjevu 1 (c) jedno i samo jedno spoj formule (I).
Microcapsules according to claims 1 characterized in that the compounds defined in claim 1 (c) are a mixture of compounds (I) and such mixture is composed of compounds (I) in monomeric form and/or oligomerized form -from 2 to 10 monomers per molecule- and/or polymerized compounds (I), being the content polymerized monomers with more than 100 monomers per molecule lower than 10% in weight % with respect to the content of monomers in weight-%. 
Mikrokapsule prema patentnom zahtjevu 1, naznačene time, što su spojevi definirani u patentnom zahtjevu 1 (c) mješavina spojeva (I) i ta mješavina je sastavljena od spojeva (I) u monomernoj formi i/ili oligomernoj formi - od 2 do 10 monomera po molekuli - i/ili polimeriziranih spojeva (I), pri čemu je sadržaj polimeriziranih monomera sa više od 100 monomera po molekuli niži od 10%, izraženo u težinskim %, u odnosu na sadržaj monomera izražen u težinskim-%.
Microcapsules according to claim 1 characterized in that the compound(s) (I) of has(have) a content in hydroxyalkyl substituents up to 50%. 
Mikrokapsule prema patentnom zahtjevu 1, naznačene time, što spoj/spojevi (I) ima/imaju sadržaj hidroksialkil supstituenata do 50%.
Microcapsules according to claims 1 to 27 characterized in that the microencapsulated material is flurochloridone. 
Mikrokapsule prema zahtjevima 1 do 27, naznačene time, što je mikroinkapsulirani materijal flurokloridon.
Microcapsules according to claims 1 to 27, characterized in that the microencapsulated material is(are) pyrethroid(s) and/or a naturally-occurring pyrethrin or mixtures thereof in the presence of antioxidants, preferably butylhydroxytoluene (BHT) and/or butylhydroxyanisol (BHA) and/or an UV protector. 
Mikrokapsule prema zahtjevima 1 do 27, naznačene time, što je/su mikroinkapsulirani materijal/materijali piretroid/piretroidi i/ili prirodni piretrin ili njihove mješavine u prisutnosti antioksidansa, poželjno butilhidroksitoluena (BHT) i/ili butilhidroksianisola (BHA) i/ili UV protektora.
Microcapsules with a polymeric wall according to claims 1 to 27, characterized in that the microencapsulated material is lambda-cyhalothrin. 
Mikrokapsule s polimernim zidom prema patentnim zahtjevima 1 do 27, naznačene time, što je mikroinkapsulirani materijal lambda-cihalotrin.
Microcapsules according to claims 1 to 27 characterized in that the microencapsulated material is gamma-cyhalothrin. 
Mikrokapsule prema patentnim zahtjevima 1 do 27, naznačene time, što je mikroinkapsulirani materijal gama-cihalotrin.
Microcapsules according to claims 1 to 27, characterized in that the microencapsulated material is supercyalothrin. 
Mikrokapsule prema patentnim zahtjevima 1 do 27, naznačene time, što je mikroinkapsulirani materijal supercihalotrin.
Microcapsules according to claims 1 to 27 characterized in that the microencapsulated material is alpha-cypermethrin. 
Mikrokapsule prema patentnim zahtjevima 1 do 27, naznačene time, što je mikroinkapsulirani materijal alfa-cipermetrin.
Microcapsules according a suitable combination of claims 1 to 27 characterized in that the microencapsulated material is trifluthrin and/or phenothrin. 
Mikrokapsule prema pogodnoj kombinaciji patentnih zahtjeva 1 do 27, naznačene time, što je mikroinkapsulirani materijal triflutrin i/ili fenotrin.
Microcapsules according a suitable combination of claims 1 to 27 characterized in that the microencapsulated material is alachlor and/or acetachlor. 
Mikrokapsule prema pogodnoj kombinaciji patentnih zahtjeva 1 do 27, naznačene time, što je mikroinkapsulirani materijal alaklor i/ili acetaklor.
Microcapsules according a suitable combination of claims 1 to 27 characterized in that the microencapsulated material is pendimethalin. 
Mikrokapsule prema pogodnoj kombinaciji patentnih zahtjeva 1 do 27, naznačene time, što je mikroinkapsulirani materijal pendimetalin.
Microcapsules according to claims 1 to 27, characterized in that the microencapsulated material is an organophosphate. 
Mikrokapsule prema patentnim zahtjevima 1 do 27, naznačene time, što je mikroinkapsulirani materijal trifluralin.
Microcapsules according to claims 1 to 27, characterized in that the microencapsulated material is chlorpyrifos. 
Mikrokapsule prema patentnim zahtjevima 1 do 27, naznačene time, što je mikroinkapsulirani materijal klorpirifos.
Microcapsules according to claims 1 to 27, characterized in that the microencapsulated material is endosulfan. 
Mikrokapsule prema patentnim zahtjevima 1 do 27, naznačene time, što je mikroinkapsulirani materijal endosulfan.
Microcapsules according to claims 1 to 27, characterized in that the microencapsulated material is a triazole fungicide. 
Mikrokapsule prema patentnim zahtjevima 1 do 27, naznačene time, što je mikroinkapsulirani materijal fenoksaprop.
Microcapsules according to claims 1 to 27, characterized in that the microencapsulated material is tebuconazole and/or propiconazole and/or ketoconazole and/or triadimenol and/or epoxiconazole. 
Mikrokapsule prema patentnim zahtjevima 1 do 27, naznačene time, što je mikroinkapsulirani materijal tebukonazol i/ili propikonazol i/ili ketokonazol i/ili triadimenol i/ili epoksikonazol.
Microcapsules according to claims 1 to 27, characterized in that the microencapsulated material is tebuconazole, wherein the oil phase inside the microcapsules contains a customary agricultural solvent of the type substituted N-alkyllactam or N,N-dimethylalkylamide. 
Mikrokapsule prema patentnim zahtjevima 1 do 27, naznačene time, što je mikroinkapsulirani materijal tebukonazol, pri čemu uljna faza unutar mikrokapsula sadrži uobičajeno poljoprivredno otapalo tipa supstituiranog N-alkillaktama ili N,N-dimetilalkilamida.
Microcapsules according to claims 1 to 27, characterized in that the microencapsulated material is fluroxypyr. 
Mikrokapsule prema patentnim zahtjevima 1 do 27, naznačene time, što je mikroinkapsulisani materijal fluroksipir.